Orthofix Medical (OFIX) Set to Announce Quarterly Earnings on Tuesday

Orthofix Medical (NASDAQ:OFIX) will be posting its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Orthofix Medical to post earnings of ($0.32) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Orthofix Medical (NASDAQ:OFIX) last released its quarterly earnings data on Tuesday, March 5th. The medical device company reported ($0.59) earnings per share for the quarter, beating the consensus estimate of ($0.60) by $0.01. Orthofix Medical had a negative return on equity of 10.63% and a negative net margin of 20.28%. The business had revenue of $200.42 million for the quarter. On average, analysts expect Orthofix Medical to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Orthofix Medical Trading Up 0.5 %

Shares of NASDAQ:OFIX traded up $0.07 during trading on Tuesday, reaching $13.16. 59,378 shares of the stock were exchanged, compared to its average volume of 398,753. The firm’s 50-day moving average price is $13.67 and its 200 day moving average price is $12.96. Orthofix Medical has a 12-month low of $9.57 and a 12-month high of $21.60. The company has a quick ratio of 1.20, a current ratio of 2.54 and a debt-to-equity ratio of 0.19.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Roth Mkm boosted their price objective on shares of Orthofix Medical from $12.00 to $15.00 and gave the stock a “neutral” rating in a research note on Thursday, March 7th. StockNews.com lowered shares of Orthofix Medical from a “hold” rating to a “sell” rating in a report on Wednesday, March 6th. Finally, JMP Securities reiterated a “market perform” rating on shares of Orthofix Medical in a report on Monday, April 22nd. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $15.50.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.